Patents-Review.com
🔗 Permalink
Assignee profile:

G. D. Searle & Co.

City:

Chicago, Illinois

Country:

United States

Published Applications:

12

Last publication date:

2006-08-29

Patent Grants:

12

Last grant date:

2006-08-29

Top Inventors for applications by G. D. Searle & Co.

These are the the leading inventors for applications assigned to G. D. Searle & Co.:

Recent patent applications by G. D. Searle & Co.

G. D. Searle & Co. based in Chicago, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2006-08-29 ✅ Patent 7,098,202 granted on 2006-08-29
US10760125
-

Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors

 #2 | 2006-08-15 ✅ Patent 7,091,219 granted on 2006-08-15
US10417340
-

Bis-sulfonamide hydroxyethyl-amino retroviral protease inhibitors

 #3 | 2006-05-02 ✅ Patent 7,037,941 granted on 2006-05-02
US10178956
-

Alpha-and Beta-amino acid hydroxyethylamino sulfamic acid derivatives useful as retroviral protease inhibitors

 #4 | 2006-04-11 ✅ Patent 7,026,333 granted on 2006-04-11
US9625384
-

Retroviral protease inhibitors

 #5 | 2005-10-13 ✅ Patent 7,161,033 granted on 2007-01-09
US20050227926A1
Chemistry; metallurgy

Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors

 #6 | 2005-10-04 ✅ Patent 6,951,886 granted on 2005-10-04
US10315254
-

Succinoylamino hydroxyethylamino sulfonyl urea derivatives useful as retroviral protease inhibitors

 #7 | 2005-08-02 ✅ Patent 6,924,286 granted on 2005-08-02
US10633376
-

α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

 #8 | 2005-03-01 ✅ Patent 6,861,539 granted on 2005-03-01
US10638479
-

Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors

 #9 | 2005-03-01 ✅ Patent 6,861,561 granted on 2005-03-01
US10259028
-

Substituted aromatic policyclic tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity

 #10 | 2005-02-22 ✅ Patent 6,858,598 granted on 2005-02-22
US9857995
-

Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia

 #11 | 2005-02-01 ✅ Patent 6,849,760 granted on 2005-02-01
US10325952
-

Method of preparing retroviral protease inhibitor intermediates

 #12 | 2005-01-25 ✅ Patent 6,846,954 granted on 2005-01-25
US10199481
-

α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
AssigneeID:

392895 ⎘